FDA Inspection 1158953 — Octapharma Plasma Inc
The FDA completed an inspection of Octapharma Plasma Inc on Nov 10, 2021 in Indianapolis, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 10, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Indianapolis, IN (United States)